PDSB
PDS BiotechnologyยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PDSB Profile
Pds Biotechnology Corporation
A clinical-stage immunotherapy company that develops hospital-based novel therapies to treat acute life-threatening neurological conditions
Biological Technology
01/22/2009
10/01/2015
NASDAQ Stock Exchange
24
12-31
Common stock
303A College Road East, Princeton, NJ 08540
--
PDS Biotechnology Corporation was incorporated under the laws of the State of Delaware on January 22, 2009. The company is a clinical-stage biotechnology company focused on discovering, developing and seeking to commercialize novel hospital-based treatment options that transform treatment patterns and life-threatening management.
